Abstract
In laboratory animals, prostaglandins have been shown to act as endogenous neuromodulators of central dopamine (DA) activity. To examine the interaction between prostaglandins and DA in man, the effect of a prostaglandin synthesis inhibitor, indomethacin, was studied on plasma concentrations of the DA metabolite, homovanillic acid (pHVA). Indomethacin (150 mg PO) as compared to placebo significantly elevated mean pHVA concentrations in eight normal subjects. Results of this study support the hypothesis that, as in animals, inhibition of prostaglandin synthesis increases central DA turnover in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Halim MS, Sjoqvist B, Anggarg E (1978) Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacol Toxicol 43:266–272
Bergstrom S, Farnebo LO, Fuxe K (1973) Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Eur J Pharmacol 21:362–368
Davidson M, Davis KL (1989) A comparison of plasma homovanillic acid concentrations in schizophrenics and normal controls. Arch Gen Psychiatry 45:561–563
Davidson M, Giordani A, Mohs RC, Aryan T, Davis KL (1987) Control of extraneous factors affecting plasma homovanillic acid concentrations. Psychiatry Res 20:307–312
Ebert MH, Kartzinel R, Cowdry RW, Goodwin FK (1980) Cerebrospinal fluid amine metabolites and the probenecid test. In: JH Wood (ed) Neurobiology of cerebrospinal fluid 1. Plenum Press, New York, pp 97–112
Fung YK, Schwartz RD (1983) An in-vivo method for testing drugs that influence striatal dopaminergic functions. Pharmacol Biochem Behav 19:231–234
Garver DL, Johnson C, Kanter DR (1982) Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events. Life Sci 31:1987–1992
Kafka MS, van Kammen DP, Bunney WE Jr (1979) Reduced cyclic AMP production in the blood platelets from schizophrenic patients. Am J Psychiatry 136:685–687
Kaiya H (1984) Prostaglandin E1 treatment of schizophrenia. Biol Psychiatry 19:457–463
Kanof PD, Johns C, Davidson M, Siever LJ, Coccaro EF, Davis KL (1986) Prostaglandin receptor sensitivity in psychiatric disorders. Arch Gen Psychiatry 43:987–993
Kanof PD, Davidson M, Johns CA, Mohs RC, Davis KL (1987) Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia. Am J Psychiatry 144:1556–1560
Kopin I, Bankiewicz KS, Harvey-White J (1988) Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP. Neuropsychopharmacology 1:119–126
Lifschitz MD (1983) Renal effects of non-steroidal anti-inflammatory agents. J Lab Clin Med 102:313–323
Maas JW, Contreras SA, Seleshi E, Bowden CL (1988) Dopamine metabolism and disposition in schizophrenic patients. Arch Gen Psychiatry 45:553–560
Nielsen JA, Sparber SB (1984) A comparative study of the effects of prostaglandins andd-amphetamine on the metabolism of 3H-dopamine continuously presented to rat brain in vivo. Pharmacol Biochem Behav 21:583–589
Ono N, Saito R, Abiru T, Kamiya H, Furukawa T (1986) Possible involvement of prostaglandins in cataleptic behavior in rats. Pharmacol Biochem Behav 25:463–467
Pandey GN, Garver DL, Tamminga C, Erickson S, Ali SI, Davis JM (1977) Postsynaptic supersensitivity in schizophrenia. Am J Psychiatry 134:518–522
Poddubiuk ZM, Kleinrok Z (1976) A comparison of the central actions of prostaglandins A1, E1, E2, F1a and F2a in the rat, II: the effect of intraventricular prostaglandins on the action of some drugs on the level and turnover of biogenic amines in the rat brain. Psychopharmacology 50:95–102
Potter WZ, Hsiao JK, Goldman SM (1989) Effect of renal clearance on plasma concentrations on homovanillic acid. Arch Gen Psychiatry 46:558–562
Rotrosen J, Miller AD, Mandio D, Traficiante LJ, Gershon S (1980) Prostaglandins, platelets and schizophrenia. Arch Gen Psychiatry 37:1047–1054
Schwartz RD, Uretsky NJ, Bianchine JR (1982a) Prostaglandin inhibition of amphetamine-induced circling in mice. Psychopharmacology 78:317–321
Schwartz RD, Uretsky NJ, Bianchine JR (1982b) Prostaglandin inhibition of apomorphine-induced circling in mice. Pharmacol Biochem Behav 17:1233–1237
Westfall TC, Kitay D (1977) The effects of prostaglandins on the release of 3H-dopamine from superinfused slices of rat striatum following electrical stimulation. Proc Soc Exp Biol Med 155:305–307
Zins GR (1975) Renal prostaglandins. Am J Med 54:14–21
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahn, R.S., Davidson, M., Kanof, P. et al. Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions. Psychopharmacology 103, 95–98 (1991). https://doi.org/10.1007/BF02244081
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244081